CRESCENT BIOPHARMA, INC. (CBIO) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for CRESCENT BIOPHARMA, INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, CRESCENT BIOPHARMA, INC.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
+34.57%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does CRESCENT BIOPHARMA, INC. actually do?
Answer:
Crescent Biopharma, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for cancer. The company is advancing two main strategies: developing CR-001, a PD-1 x VEGF bispecific antibody intended to serve as a foundational immuno-oncology backbone, and building a portfolio of antibody-drug conjugates (ADCs). Crescent aims to combine these approaches to create synergistic cancer treatments. The company initiated a global Phase 1/2 trial for CR-001 in early 2026 and anticipates initiating clinical trials for CR-002 and CR-003 in 2026. Its pipeline is built upon licensed intellectual property from Paragon Therapeutics and collaborations, notably with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Question:
What are CRESCENT BIOPHARMA, INC.'s revenue drivers?
Answer:
Revenue is primarily derived from license fees and potential future milestone payments and royalties from collaboration and license agreements, notably with Kelun for CR-001. The company does not currently generate revenue from product sales.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required